Zobrazeno 1 - 10
of 167
pro vyhledávání: '"David C. Rice"'
Autor:
Nathaniel, Deboever, Hope A, Feldman, Wayne L, Hofstetter, Reza J, Mehran, Ravi, Rajaram, David C, Rice, Jack A, Roth, Boris, Sepesi, Stephen G, Swisher, Ara A, Vaporciyan, Garrett L, Walsh, Mara B, Antonoff
Publikováno v:
Journal of Surgical Research. 277:125-130
The lung represents a frequent site of spread for metastatic melanoma, which has historically been managed with surgical resection achieving promising outcomes. We hypothesized that the role of surgery in the management of melanoma pulmonary metastas
Autor:
Mara B. Antonoff, Song Gao, Saumil Gandhi, John V. Heymach, Arlene M. Correa, Vivek Verma, Zhongxing Liao, James W. Welsh, Ravi Rajaram, Wayne L. Hofstetter, Ritsuko Komaki, Garrett L. Walsh, Lei Feng, Joe Y. Chang, Donald A. Berry, Aileen Chen, R Sadagopan, Stephen E. McRae, Peter A Balter, Reza J. Mehran, Matthew S. Ning, Jack A. Roth, Craig DeGraaf, Steven H. Lin, Melenda Jeter, Ara A. Vaporciyan, Xiaochun Wang, Paige L. Nitsch, Michael S. O'Reilly, Quynh-Nhu Nguyen, Boris Sepesi, Julianne M. Pollard-Larkin, David C. Rice, Stephen G. Swisher, Percy Lee
Publikováno v:
Lancet Oncol
Summary Background A previous pooled analysis of the STARS and ROSEL trials showed higher survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early-stage non-small-cell lung cancer (NSCLC), but that analysis had no
Autor:
Boris Sepesi, Stephen G. Swisher, Wayne L. Hofstetter, Reza J. Mehran, Garrett L. Walsh, Jack A. Roth, David C. Rice, Nicolas Zhou, Arlene M. Correa, Mara B. Antonoff, Van K. Morris, Erin M. Corsini, Ara A. Vaporciyan, Kyle G. Mitchell
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 162:296-305
Objectives Although colorectal cancer bowel segment location has been shown to independently predict the outcomes in early stage disease, it has not been previously studied in the setting of pulmonary metastases. We sought to determine whether colore
Autor:
John V. Heymach, Barbara Mino, J. Jack Lee, Pedro Rocha, Cesar A. Moran, David C. Rice, Edwin R. Parra, Humam Kadara, Boris Sepesi, Lei Feng, Luisa M. Solis, Carmen Behrens, Ignacio I. Wistuba, Don L. Gibbons, Jianjun Zhang, Chad J. Creighton, Jaime Rodriguez-Canales
Publikováno v:
Clinical Lung Cancer. 22:e415-e424
Introduction Immune infiltration in lung adenocarcinomas (LUADs) has been associated with response to immune checkpoint inhibitors. Clinical features underlying differential responses of patients with LUADs to immunotherapy are not well understood. H
Autor:
Wayne L. Hofstetter, Ara A. Vaporciyan, Mara B. Antonoff, Ravi Rajaram, Nicolas Zhou, Boris Sepesi, David C. Rice, Andres Zorrilla-Vaca, Reza J. Mehran, Hope A. Feldman
Publikováno v:
Journal of Surgical Oncology. 123:1633-1639
BACKGROUND: For patients with bilateral pulmonary metastases, staged resections have historically been the preferred surgical intervention. During the spring of 2020, the COVID-19 pandemic made patient travel to the hospital challenging and necessita
Autor:
Cheuk Hong Leung, Wayne L. Hofstetter, John V. Heymach, Alexandre Reuben, Myrna C.B. Godoy, Ara A. Vaporciyan, Padmanee Sharma, Yasir Elamin, Neda Kalhor, Robert R. Jenq, Junya Fujimoto, Tina Cascone, Anne S. Tsao, William N. William, Charles Lu, Frank E. Mott, Nadim J. Ajami, Don L. Gibbons, Jack A. Roth, David C. Rice, Luisa M. Solis, Hai T. Tran, Brett W. Carter, Lauren Averett Byers, Andrew Futreal, Lorenzo Federico, Annikka Weissferdt, Garrett L. Walsh, Reza J. Mehran, Chantale Bernatchez, George R. Blumenschein, Jennifer A. Wargo, Heather Lin, Cara Haymaker, Xiuning Le, Jonathan M. Kurie, Mehmet Altan, James P. Allison, Stephen G. Swisher, Edwin R. Parra, Boris Sepesi, Hitoshi Dejima, Frank V. Fossella, Jianjun Zhang, Bonnie S. Glisson, Mara B. Antonoff, Abdul Wadud Khan, Apar Pataer, Alejandro Francisco-Cruz, Ignacio I. Wistuba, Humam Kadara, J. Jack Lee, Ferdinandos Skoulidis
Publikováno v:
Nat Med
Ipilimumab improves clinical outcomes when combined with nivolumab in metastatic non-small cell lung cancer (NSCLC), but its efficacy and impact on the immune microenvironment in operable NSCLC remain unclear. We report the results of the phase 2 ran
Autor:
Pedro Rocha, Dzifa Y. Douse, Lixia Diao, Humam Kadara, Jianjun Zhang, Debora A. Ledesma, Jose Luis Solorzano, John V. Heymach, Ruth Salazar, Luisa M. Solis, Neda Kalhor, Barbara Mino, J. Jack Lee, Don L. Gibbons, Cesar A. Moran, David C. Rice, Carmen Behrens, Pamela Villalobos, Ara A. Vaporciyan, Jiexin Zhang, Hitoshi Dejima, Annikka Weissferdt, Kyle G. Mitchell, Tina Cascone, Edwin Parra-Cuentas, Boris Sepesi, Xiuning Le, Ignacio I. Wistuba
Publikováno v:
Cancer Immunology, Immunotherapy
Introduction CD73 is a membrane-bound enzyme crucial in adenosine generation. The adenosinergic pathway plays a critical role in immunosuppression and in anti-tumor effects of immune checkpoint inhibitors (ICI). Here, we interrogated CD73 expression
Autor:
Kyle G. Mitchell, Edwin R. Parra, Jiexin Zhang, David B. Nelson, Erin M. Corsini, Pamela Villalobos, Cesar A. Moran, Ferdinandos Skoulidis, Ignacio I. Wistuba, Junya Fujimoto, Jack A. Roth, Mara B. Antonoff, J. Jack Lee, Ara A. Vaporciyan, Wayne L. Hofstetter, Reza J. Mehran, Stephen G. Swisher, David C. Rice, Boris Sepesi, Garrett L. Walsh, Carmen Behrens, Neda Kalhor, Annikka Weissferdt, John V. Heymach, null AstraZeneca, null Bayer, null GlaxoSmithKline
Publikováno v:
Ann Thorac Surg
BACKGROUND: Mutations in the serine-threonine kinase LKB1/STK11 have been implicated in mediating resistance to checkpoint blockade among patients with advanced lung adenocarcinoma. We sought to examine the associations between clinicopathologic char
Autor:
Tina Cascone, Ting Xu, Quynh Nhu Nguyen, David C. Rice, Jack A. Roth, Saumil Gandhi, Wayne L. Hofstetter, Zhongxing Liao, Arlene M. Correa, Mara B. Antonoff, Anne S. Tsao, Ara A. Vaporciyan, Reza J. Mehran, Ravi Rajaram, Stephen G. Swisher, Boris Sepesi, Vassiliki A. Papadimitrakopoulou, Garrett L. Walsh
Publikováno v:
Clinical Lung Cancer. 21:e294-e301
Introduction The standard of care for stage IIIA (N2) non–small-cell lung cancer (NSCLC) includes concurrent definitive chemoradiation (dCRT) followed by durvalumab, thus challenging the role of surgery in resectable patients. We assessed locoregio
Autor:
Erin M. Corsini, David C. Rice, Ara A. Vaporciyan, Kyle G. Mitchell, Jack A. Roth, Mara B. Antonoff, Stephen G. Swisher, Wayne L. Hofstetter, Boris Sepesi, Garrett L. Walsh, Reza J. Mehran
Publikováno v:
Journal of Surgical Oncology. 122:515-522
Background and objectives It is unclear if a specific strategy for simultaneous treatment of primary thymic neoplasms and pleural metastases confers benefit for Masaoka stage IVA disease. We reviewed our experience with thymic neoplasms with concurre